000705 浙江震元
已收盘 07-28 15:00:00
资讯
新帖
简况
7月18日浙江震元(000705)龙虎榜数据:机构净卖出1486.64万元
证券之星 · 07-18
7月18日浙江震元(000705)龙虎榜数据:机构净卖出1486.64万元
浙江震元:合成生物项目依托生物发酵与分离纯化经验布局小品种氨基酸市场
证券之星 · 07-17
浙江震元:合成生物项目依托生物发酵与分离纯化经验布局小品种氨基酸市场
浙江震元:该酯键化合物目前还处于实验室动物试验阶段
证券之星 · 07-17
浙江震元:该酯键化合物目前还处于实验室动物试验阶段
合成生物概念走强 生物股份、浙江震元涨停
E公司 · 07-17
合成生物概念走强 生物股份、浙江震元涨停
异动快报:浙江震元(000705)7月16日9点30分触及涨停板
证券之星 · 07-16
异动快报:浙江震元(000705)7月16日9点30分触及涨停板
浙江震元:公司用于癌痛治疗的创新型新药尚处于探索性研究阶段
证券之星 · 07-16
浙江震元:公司用于癌痛治疗的创新型新药尚处于探索性研究阶段
浙江震元:公司再融资项目处于问询回复阶段
问董秘 · 06-30
浙江震元:公司再融资项目处于问询回复阶段
浙江震元:因披露2024年年报及2025年一季报更新定增材料
证券之星 · 06-26
浙江震元:因披露2024年年报及2025年一季报更新定增材料
浙江震元:合成生物项目以组氨酸等为核心产品
证券之星 · 06-26
浙江震元:合成生物项目以组氨酸等为核心产品
浙江震元股价微跌0.12% 公布年度分红方案
金融界 · 06-20
浙江震元股价微跌0.12% 公布年度分红方案
浙江震元:公司向特定对象发行股票事项的相关回复已递交交易所
证券之星 · 06-19
浙江震元:公司向特定对象发行股票事项的相关回复已递交交易所
浙江震元:生物定向合成上虞基地项目将有助于提升公司营业收入、盈利能力
证券之星 · 06-12
浙江震元:生物定向合成上虞基地项目将有助于提升公司营业收入、盈利能力
浙江震元:公司下属子公司与扬子江药业有业务合作
证券之星 · 06-06
浙江震元:公司下属子公司与扬子江药业有业务合作
浙江震元:震元生物合成生物项目预计三季度投产
证券之星 · 06-06
浙江震元:震元生物合成生物项目预计三季度投产
浙江震元:公司向特定对象发行股票事项尚在推进中,发行对象未确定
证券之星 · 06-04
浙江震元:公司向特定对象发行股票事项尚在推进中,发行对象未确定
每周股票复盘:浙江震元(000705)2024年度股东大会顺利召开多项议案通过
证券之星 · 05-23
每周股票复盘:浙江震元(000705)2024年度股东大会顺利召开多项议案通过
浙江震元:组氨酸产品有一定的抗氧化功效
证券之星 · 05-20
浙江震元:组氨酸产品有一定的抗氧化功效
浙江震元:公司生物定向合成上虞基地项目有组氨酸(盐酸组氨酸)产品
证券之星 · 05-15
浙江震元:公司生物定向合成上虞基地项目有组氨酸(盐酸组氨酸)产品
浙江震元:公司重视经营发展,优化业务布局,聚焦医药工业,布局合成生物赛道,培育新的业务增长点
证券之星 · 05-14
浙江震元:公司重视经营发展,优化业务布局,聚焦医药工业,布局合成生物赛道,培育新的业务增长点
浙江震元:公司2025年3月31日股东数为32,139
证券之星 · 05-09
浙江震元:公司2025年3月31日股东数为32,139
加载更多
公司概况
公司名称:
浙江震元股份有限公司
所属行业:
批发业
上市日期:
1997-04-10
主营业务:
浙江震元股份有限公司的主营业务是医药流通、医药工业、中药饮片加工和健康产品。公司的主要产品是原料药、制剂、批发、零售。
发行价格:
4.45
{"stockData":{"symbol":"000705","market":"SZ","secType":"STK","nameCN":"浙江震元","latestPrice":9.33,"timestamp":1753686180000,"preClose":9.33,"halted":0,"volume":16140000,"delay":0,"changeRate":0,"floatShares":282000000,"shares":334000000,"eps":0.1538,"marketStatus":"已收盘","change":0,"latestTime":"07-28 15:00:00","open":9.33,"high":9.41,"low":9.3,"amount":151000000,"amplitude":0.0118,"askPrice":9.33,"askSize":938,"bidPrice":9.32,"bidSize":274,"shortable":0,"etf":0,"ttmEps":0.1538,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1753752600000},"marketStatusCode":5,"adr":0,"adjPreClose":9.33,"symbolType":"stock","openAndCloseTimeList":[[1753666200000,1753673400000],[1753678800000,1753686000000]],"highLimit":10.26,"lowLimit":8.4,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":334123286,"isCdr":false,"pbRate":1.56,"roa":"--","peRate":60.663199,"roe":"1.81%","epsLYR":0.1,"committee":0.230114,"marketValue":3117000000,"turnoverRate":0.0572,"status":2,"floatMarketCap":2631000000},"requestUrl":"/m/hq/s/000705","defaultTab":"news","newsList":[{"id":"2552546543","title":"7月18日浙江震元(000705)龙虎榜数据:机构净卖出1486.64万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2552546543","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552546543?lang=zh_cn&edition=full","pubTime":"2025-07-18 17:12","pubTimestamp":1752829977,"startTime":"0","endTime":"0","summary":"证券之星消息,沪深交易所2025年7月18日公布的交易公开信息显示,浙江震元因日换手率达到20%的前5只证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2025年7月18日收盘,浙江震元报收于10.38元,下跌1.61%,换手率47.3%,成交量133.38万手,成交额14.94亿元。从龙虎榜公布的当日买卖数据来看,机构合计净卖出1486.64万元。从龙虎榜数据可以发现和研究机构、游资和散户的资金动向。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071800027406.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","000705"],"gpt_icon":0},{"id":"2552012461","title":"浙江震元:合成生物项目依托生物发酵与分离纯化经验布局小品种氨基酸市场","url":"https://stock-news.laohu8.com/highlight/detail?id=2552012461","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552012461?lang=zh_cn&edition=full","pubTime":"2025-07-17 16:00","pubTimestamp":1752739237,"startTime":"0","endTime":"0","summary":"证券之星消息,浙江震元(000705)07月17日在投资者关系平台上答复投资者关心的问题。投资者提问:贵司视合成生物为发展新质生产力、实现公司未来五年跨越式发展的关键,请问在合成生物的关键技术如基因编辑技术、DNA合成与组装、代谢工程等领域,贵司是否已掌握?浙江震元回复:您好,感谢您的关注。合成生物项目依托公司多年在生物制药方面所积累的生物发酵经验、分离纯化经验等既有优势基础之上,通过引入合成生物技术构建的工程菌布局并深耕小品种氨基酸市场。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071700023079.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000705","BK0250"],"gpt_icon":0},{"id":"2552101975","title":"浙江震元:该酯键化合物目前还处于实验室动物试验阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2552101975","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552101975?lang=zh_cn&edition=full","pubTime":"2025-07-17 15:57","pubTimestamp":1752739036,"startTime":"0","endTime":"0","summary":"根据专利说明,该酯键化合物是一种全新的化合物,在一半的摩尔量下,该酯键化合物比治疗疼痛的一线药物‘普瑞巴林’的镇痛药效强、起效快、镇痛时间长、药效起伏小,副作用小。请问贵公司,该发明关于该酯键化合物的治疗效果与治疗疼痛的一线药物“普瑞巴林”的效果比较有无夸大的成分?该酯键化合物目前还处于实验室动物试验阶段,动物试验结果显示镇痛效果较好。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071700022582.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000705","BK0250"],"gpt_icon":0},{"id":"2552177859","title":"合成生物概念走强 生物股份、浙江震元涨停","url":"https://stock-news.laohu8.com/highlight/detail?id=2552177859","media":"E公司","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552177859?lang=zh_cn&edition=full","pubTime":"2025-07-17 10:28","pubTimestamp":1752719311,"startTime":"0","endTime":"0","summary":"人民财讯7月17日电,合成生物概念走强,截至发稿,生物股份、浙江震元等涨停,科兴制药、泓博医药等涨超5%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071710283195458d11&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071710283195458d11&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600201","BK0250","BK0028","BK0077","BK0185","BK0012","BK0188","BK0046","BK0239","BK0196","000705"],"gpt_icon":0},{"id":"2551115460","title":"异动快报:浙江震元(000705)7月16日9点30分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2551115460","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551115460?lang=zh_cn&edition=full","pubTime":"2025-07-16 09:36","pubTimestamp":1752629806,"startTime":"0","endTime":"0","summary":"证券之星7月16日盘中消息,9点30分浙江震元触及涨停板。目前价格9.59,上涨9.98%。其所属行业医药商业目前下跌。领涨股为润达医疗。该股为医药商业,优化生育(三孩),中药概念热股,当日医药商业概念上涨0.66%,优化生育(三孩)概念上涨0.43%,中药概念上涨0.31%。7月15日的资金流向数据方面,主力资金净流入30.42万元,占总成交额0.42%,游资资金净流入63.59万元,占总成交额0.87%,散户资金净流出94.01万元,占总成交额1.29%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071600008282.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","000705"],"gpt_icon":0},{"id":"2551711338","title":"浙江震元:公司用于癌痛治疗的创新型新药尚处于探索性研究阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2551711338","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551711338?lang=zh_cn&edition=full","pubTime":"2025-07-16 09:03","pubTimestamp":1752627790,"startTime":"0","endTime":"0","summary":"证券之星消息,浙江震元(000705)07月15日在投资者关系平台上答复投资者关心的问题。投资者提问:贵司全资子公司震云制药今年与中国医学科学院药物研究所联合推出了治疗肺癌细胞、结直肠癌细胞和胶质瘤细胞等各种癌症的新方案——迷迭香酸和青藤碱的联合用药,请问该方案是治疗癌症的创新方案吗?未来多久能推出相关治疗药品?浙江震元回复:您好,感谢您的提问。公司用于癌痛治疗的创新型新药尚处于探索性研究阶段,暂无上市计划。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071600006594.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","000705"],"gpt_icon":0},{"id":"2547309413","title":"浙江震元:公司再融资项目处于问询回复阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2547309413","media":"问董秘","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547309413?lang=zh_cn&edition=full","pubTime":"2025-06-30 20:45","pubTimestamp":1751287500,"startTime":"0","endTime":"0","summary":"投资者提问:尊敬的吴董,您好,经查询深交所发行上市审核信息公开网站,公司再融资进展情况,公司2024年12月6日公司公告已经回复问询,但是目前公开信息显示进度为已经问询,并没有进展到已经回复,出现这问题是公司问题还是监管开展第二轮问询工作,或者是交易所信息公开不及时?董秘回答(浙江震元SZ000705):您好,感谢您的提问。公司再融资项目当前处于问询回复阶段。查看更多董秘问答>>免责声明:本信息由新浪财经从公开信息中摘录,不构成任何投资建议;新浪财经不保证数据的准确性,内容仅供参考。\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/dongmiqa/2025-06-30/doc-infcwksi6190398.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["162717","BK0250","000705"],"gpt_icon":0},{"id":"2546202516","title":"浙江震元:因披露2024年年报及2025年一季报更新定增材料","url":"https://stock-news.laohu8.com/highlight/detail?id=2546202516","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546202516?lang=zh_cn&edition=full","pubTime":"2025-06-26 16:33","pubTimestamp":1750926784,"startTime":"0","endTime":"0","summary":"证券之星消息,浙江震元(000705)06月26日在投资者关系平台上答复投资者关心的问题。投资者提问:尊敬的吴董!您好2024年10月26提交再融资定增申报稿,但是2025年6月25日公司再次提交定增的相关材料,请问是什么原因呢,是再审过程中监管要求修正,还是公司主动撤回修正?具体修正那些重要内容,麻烦答复,谢谢。浙江震元回复:您好,感谢您的提问。因公司披露了2024年年报及2025年一季报,按照审核要求,将定增相关材料进行数据更新。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025062600025787.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","000705"],"gpt_icon":0},{"id":"2546204016","title":"浙江震元:合成生物项目以组氨酸等为核心产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2546204016","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546204016?lang=zh_cn&edition=full","pubTime":"2025-06-26 16:27","pubTimestamp":1750926434,"startTime":"0","endTime":"0","summary":"证券之星消息,浙江震元(000705)06月26日在投资者关系平台上答复投资者关心的问题。投资者提问:合成生物这一块投产后产品有组氨酸菌粉吗?另外化学制药这一块扩产提质后预计年销量能增加多少?浙江震元回复:您好,感谢您的提问。合成生物项目目前以组氨酸(盐酸组氨酸)、左旋多巴、酪氨酸为核心产品,后续公司将继续研究开发新的产品。公司原料药项目搬迁至新厂区后,现有厂区的原料药旧产能会适时淘汰,合计产能会有一定提升,至于年销量的增加需视届时市场销售情况而定。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025062600025638.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000705","BK0250"],"gpt_icon":0},{"id":"2544017522","title":"浙江震元股价微跌0.12% 公布年度分红方案","url":"https://stock-news.laohu8.com/highlight/detail?id=2544017522","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544017522?lang=zh_cn&edition=full","pubTime":"2025-06-20 22:39","pubTimestamp":1750430362,"startTime":"0","endTime":"0","summary":"浙江震元6月20日股价报8.09元,较前一交易日下跌0.01元,跌幅0.12%。当日开盘价为8.13元,最高触及8.18元,最低下探至8.06元,成交量为44880手,成交金额达0.36亿元。浙江震元属于医药商业板块,公司主营业务涵盖医药流通、医药制造等领域。公司于6月20日晚间发布2024年度权益分派方案,拟向全体股东每10股派发现金红利0.6元(含税)。本次分红股权登记日为2025年6月26日,除权除息日为6月27日。6月20日主力资金净流入71.7万元,占流通市值的0.03%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/06/20223951212192.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["000705","BK0250"],"gpt_icon":0},{"id":"2544043130","title":"浙江震元:公司向特定对象发行股票事项的相关回复已递交交易所","url":"https://stock-news.laohu8.com/highlight/detail?id=2544043130","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544043130?lang=zh_cn&edition=full","pubTime":"2025-06-19 15:06","pubTimestamp":1750316779,"startTime":"0","endTime":"0","summary":"证券之星消息,浙江震元(000705)06月19日在投资者关系平台上答复投资者关心的问题。投资者提问:尊敬的吴董,您好,经查询深交所发行上市审核信息公开信息,公司公开发行于2024年11月14日已经完成问询工作,目前到回复阶段,请问公司是否已经提交回复材料,谢谢。浙江震元回复:你好,感谢您的提问。公司向特定对象发行股票事项的相关回复已递交交易所,目前仍处于审核过程中。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025061900016021.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000705","BK0250"],"gpt_icon":0},{"id":"2542591633","title":"浙江震元:生物定向合成上虞基地项目将有助于提升公司营业收入、盈利能力","url":"https://stock-news.laohu8.com/highlight/detail?id=2542591633","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542591633?lang=zh_cn&edition=full","pubTime":"2025-06-12 17:03","pubTimestamp":1749719009,"startTime":"0","endTime":"0","summary":"证券之星消息,浙江震元06月12日在投资者关系平台上答复投资者关心的问题。上虞合成物在国内竞争格局如何?预计生物定向合成上虞基地项目建成和投入使用后,将有助于扩大公司的生产经营规模,有助于提升公司营业收入、盈利能力,具体视投产及市场销售情况。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025061200024197.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000705"],"gpt_icon":0},{"id":"2541836398","title":"浙江震元:公司下属子公司与扬子江药业有业务合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2541836398","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541836398?lang=zh_cn&edition=full","pubTime":"2025-06-06 15:37","pubTimestamp":1749195455,"startTime":"0","endTime":"0","summary":"证券之星消息,浙江震元(000705)06月06日在投资者关系平台上答复投资者关心的问题。投资者提问:董秘,您好。请问公司是否与吉林通化金马阿尔茨海默创新药有业务合作?另外和江苏泰州药业巨头扬子江药业集团也有业务合作?浙江震元回复:您好,感谢您的提问。公司下属子公司震元制药、震元连锁以及参股公司华润震元与扬子江药业有业务合作。公司与吉林通化金马暂无业务合作。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025060600018356.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000705","BK0250"],"gpt_icon":0},{"id":"2541835378","title":"浙江震元:震元生物合成生物项目预计三季度投产","url":"https://stock-news.laohu8.com/highlight/detail?id=2541835378","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541835378?lang=zh_cn&edition=full","pubTime":"2025-06-06 15:18","pubTimestamp":1749194295,"startTime":"0","endTime":"0","summary":"证券之星消息,浙江震元(000705)06月06日在投资者关系平台上答复投资者关心的问题。投资者提问:董秘,浙江震元上虞合成生物项目是否只有增发配股成功后才能启动生产?如增发不成功就会报废减值处理是么?浙江震元回复:您好,感谢您的提问。震元生物合成生物项目预计三季度投产。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025060600017590.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","000705"],"gpt_icon":0},{"id":"2540378810","title":"浙江震元:公司向特定对象发行股票事项尚在推进中,发行对象未确定","url":"https://stock-news.laohu8.com/highlight/detail?id=2540378810","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540378810?lang=zh_cn&edition=full","pubTime":"2025-06-04 15:54","pubTimestamp":1749023685,"startTime":"0","endTime":"0","summary":"证券之星消息,浙江震元(000705)06月04日在投资者关系平台上答复投资者关心的问题。投资者提问:亲爱的董秘,您好。请问贵公司向特定对象发行股票有娃哈哈集团吗?浙江震元回复:您好,感谢您的提问。公司向特定对象发行股票事项尚在推进中,发行对象未确定。最终发行对象需在本事项获得监管层核准、批复后,由董事会在股东大会的授权范围内,按照相关法律、行政法规、部门规章及规范性文件的规定,根据竞价结果与本次发行的保荐人(主承销商)协商确定。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025060400020430.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","000705"],"gpt_icon":0},{"id":"2537154033","title":"每周股票复盘:浙江震元(000705)2024年度股东大会顺利召开多项议案通过","url":"https://stock-news.laohu8.com/highlight/detail?id=2537154033","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537154033?lang=zh_cn&edition=full","pubTime":"2025-05-24 04:04","pubTimestamp":1748030654,"startTime":"0","endTime":"0","summary":"截至2025年5月23日收盘,浙江震元报收于8.27元,较上周的8.19元上涨0.98%。本周,浙江震元5月23日盘中最高价报8.5元。浙江震元当前最新总市值27.63亿元,在医药商业板块市值排名27/31,在两市A股市值排名4302/5148。本周关注点公司公告汇总:浙江震元2024年度股东大会顺利召开,多项议案获得通过公司公告汇总浙江震元2024年度股东大会于2025年5月19日下午15:00在绍兴市延安东路558号公司331会议室召开,董事长吴海明主持。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025052400007494.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000705","BK0250"],"gpt_icon":0},{"id":"2536665253","title":"浙江震元:组氨酸产品有一定的抗氧化功效","url":"https://stock-news.laohu8.com/highlight/detail?id=2536665253","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536665253?lang=zh_cn&edition=full","pubTime":"2025-05-20 11:37","pubTimestamp":1747712229,"startTime":"0","endTime":"0","summary":"证券之星消息,浙江震元(000705)05月19日在投资者关系平台上答复投资者关心的问题。投资者提问:浙江震元合成生物基地的组氨酸产品化妆品领域有抗衰老功效吗浙江震元回复:您好,感谢您的提问。组氨酸产品有一定的抗氧化功效,但现阶段主要用于特殊人群或动物的营养强化领域。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025052000013761.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","000705"],"gpt_icon":0},{"id":"2535899887","title":"浙江震元:公司生物定向合成上虞基地项目有组氨酸(盐酸组氨酸)产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2535899887","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535899887?lang=zh_cn&edition=full","pubTime":"2025-05-15 16:06","pubTimestamp":1747296382,"startTime":"0","endTime":"0","summary":"证券之星消息,浙江震元(000705)05月15日在投资者关系平台上答复投资者关心的问题。投资者提问:你好董秘:麦角硫因的化学合成通常以L-组氨酸为起始原料,公司是否有L-组氨酸的产品?浙江震元回复:您好,感谢您的提问。公司生物定向合成上虞基地项目有组氨酸(盐酸组氨酸)产品。目前,项目各工段已基本安装完成,调试进行中。预计三季度投产。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025051500022351.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000705","BK0250"],"gpt_icon":0},{"id":"2535108058","title":"浙江震元:公司重视经营发展,优化业务布局,聚焦医药工业,布局合成生物赛道,培育新的业务增长点","url":"https://stock-news.laohu8.com/highlight/detail?id=2535108058","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535108058?lang=zh_cn&edition=full","pubTime":"2025-05-14 08:57","pubTimestamp":1747184235,"startTime":"0","endTime":"0","summary":"证券之星消息,浙江震元(000705)05月14日在投资者关系平台上答复投资者关心的问题。投资者提问:合成生物生产线投产遥遥无期,无任何新药研发上市,收购中成药生产企业犹如海市蜃楼,公司持有的华东医药股份又不套现资金出来聚焦主业,公司作为国企按这个发展思路只会大幅落后同行和社会。浙江震元回复:您好,感谢您的关注,公司重视经营发展,优化业务布局,聚焦医药工业,布局合成生物赛道,培育新的业务增长点。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025051400006904.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000705","BK0250"],"gpt_icon":0},{"id":"2534192465","title":"浙江震元:公司2025年3月31日股东数为32,139","url":"https://stock-news.laohu8.com/highlight/detail?id=2534192465","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534192465?lang=zh_cn&edition=full","pubTime":"2025-05-09 08:42","pubTimestamp":1746751341,"startTime":"0","endTime":"0","summary":"证券之星消息,浙江震元(000705)05月08日在投资者关系平台上答复投资者关心的问题。投资者提问:董秘你好,请问公司近期股东人数是多少?谢谢浙江震元回复:您好,感谢您的提问。公司股东人数请关注公司定期报告。公司2025年3月31日股东数为32,139。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025050900005635.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000705","BK0250"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1753726538967,"stockEarnings":[{"period":"1week","weight":-0.0557},{"period":"1month","weight":0.112},{"period":"3month","weight":0.2048},{"period":"6month","weight":0.2301},{"period":"1year","weight":0.2769},{"period":"ytd","weight":0.1881}],"compareEarnings":[{"period":"1week","weight":0.0107},{"period":"1month","weight":0.0507},{"period":"3month","weight":0.0947},{"period":"6month","weight":0.1069},{"period":"1year","weight":0.2446},{"period":"ytd","weight":0.0734}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"浙江震元股份有限公司","boardCode":"AI0051","boardName":"批发业","stockholders":"32139人(较上一季度减少2.27%)","perCapita":"8773股","listingDate":"1997-04-10","address":"浙江省绍兴市越城区稽山街道延安东路558号","registeredCapital":"33412万元","survey":" 浙江震元股份有限公司的主营业务是医药流通、医药工业、中药饮片加工和健康产品。公司的主要产品是原料药、制剂、批发、零售。","listedPrice":4.45},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.4","shortVersion":"4.34.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"浙江震元(000705)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供浙江震元(000705)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"浙江震元,000705,浙江震元股票,浙江震元股票老虎,浙江震元股票老虎国际,浙江震元行情,浙江震元股票行情,浙江震元股价,浙江震元股市,浙江震元股票价格,浙江震元股票交易,浙江震元股票购买,浙江震元股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"浙江震元(000705)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供浙江震元(000705)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}